400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / MAPK/ERK Pathway / Raf / AZ 628
CAS No.: 878739-06-1
AZ 628 is a pan-Raf inhibitor for BRAF, BRAFV600E, and c-Raf-1 with IC50 of 105 nM, 34 nM and 29 nM, also inhibits VEGFR2, DDR2, Lyn, Flt1, FMS, etc.
生物活性
实验方案
技术信息
CAS号 | 878739-06-1 | 储存条件 |
|
|
分子式 | C27H25N5O2 | 运输 | 蓝冰 | |
分子量 | 451.52 | 别名 |
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
697 cell | - | Growth inhibition assay | - | Inhibition of human 697 cell growth in a cell viability assay, IC50=363.88 μM | SANGER |
A101D cell | - | Growth inhibition assay | - | Inhibition of human A101D cell growth in a cell viability assay, IC50=5.82 nM | SANGER |
A375 cells | - | Function assay | 75 mins | Inhibition of BRAF V600E mutant-mediated ERK phosphorylation in human A375 cells after 75 mins, IC50=0.015 μM | 23398453 |
ACN cell | - | Growth inhibition assay | - | Inhibition of human ACN cell growth in a cell viability assay, IC50=0.101 nM | SANGER |
BB49-HNC cell | - | Growth inhibition assay | - | Inhibition of human BB49-HNC cell growth in a cell viability assay, IC50=0.3518 μM | SANGER |
Calu-6 cell | - | Growth inhibition assay | - | Inhibition of human Calu-6 cell growth in a cell viability assay, IC50=51.47 nM | SANGER |
CGTH-W-1 cell | - | Growth inhibition assay | - | Inhibition of human CGTH-W-1 cell growth in a cell viability assay, IC50=121.3 nM | SANGER |
COLO-829 cell | - | Growth inhibition assay | - | Inhibition of human COLO-829 cell growth in a cell viability assay, IC50=25.65 nM | SANGER |
CP66-MEL cell | - | Growth inhibition assay | - | Inhibition of human CP66-MEL cell growth in a cell viability assay, IC50=131.76 nM | SANGER |
D-392MG cell | - | Growth inhibition assay | - | Inhibition of human D-392MG cell growth in a cell viability assay, IC50=0.35607 μM | SANGER |
DU-4475 cell | - | Growth inhibition assay | - | Inhibition of human DU-4475 cell growth in a cell viability assay, IC50=10.23 nM | SANGER |
EM-2 cell | - | Growth inhibition assay | - | Inhibition of human EM-2 cell growth in a cell viability assay, IC50=195.91 nM | SANGER |
GDM-1 cell | - | Growth inhibition assay | - | Inhibition of human GDM-1 cell growth in a cell viability assay, IC50=0.22947 μM | SANGER |
HCC2998 cell | - | Growth inhibition assay | - | Inhibition of human HCC2998 cell growth in a cell viability assay, IC50=0.22187 μM | SANGER |
HL-60 cell | - | Growth inhibition assay | - | Inhibition of human HL-60 cell growth in a cell viability assay, IC50=154.41 nM | SANGER |
HT-144 cell | - | Growth inhibition assay | - | Inhibition of human HT-144 cell growth in a cell viability assay, IC50=6.61 nM | SANGER |
IST-MEL1 cell | - | Growth inhibition assay | - | Inhibition of human IST-MEL1 cell growth in a cell viability assay, IC50=204.13 nM | SANGER |
K5 cell | - | Growth inhibition assay | - | Inhibition of human K5 cell growth in a cell viability assay, IC50=134.2 nM | SANGER |
K-562 cell | - | Growth inhibition assay | - | Inhibition of human K-562 cell growth in a cell viability assay, IC50=0.66695 μM | SANGER |
KMOE-2 cell | - | Growth inhibition assay | - | Inhibition of human KMOE-2 cell growth in a cell viability assay, IC50=115.88 nM | SANGER |
KS-1 cell | - | Growth inhibition assay | - | Inhibition of human KS-1 cell growth in a cell viability assay, IC50=0.39337 μM | SANGER |
LAMA-84 cell | - | Growth inhibition assay | - | Inhibition of human LAMA-84 cell growth in a cell viability assay, IC50=192.42 nM | SANGER |
LAN-6 cell | - | Growth inhibition assay | - | Inhibition of human LAN-6 cell growth in a cell viability assay, IC50=0.68236 μM | SANGER |
LB2518-MEL cell | - | Growth inhibition assay | - | Inhibition of human LB2518-MEL cell growth in a cell viability assay, IC50=4.76 nM | SANGER |
LS-513 cell | - | Growth inhibition assay | - | Inhibition of human LS-513 cell growth in a cell viability assay, IC50=74.15 nM | SANGER |
MEG-01 cell | - | Growth inhibition assay | - | Inhibition of human MEG-01 cell growth in a cell viability assay, IC50=0.376 μM | SANGER |
ML-2 cell | - | Growth inhibition assay | - | Inhibition of human ML-2 cell growth in a cell viability assay, IC50=368.86 nM | SANGER |
MMAC-SF cell | - | Growth inhibition assay | - | Inhibition of human MMAC-SF cell growth in a cell viability assay, IC50=40.07 nM | SANGER |
MZ1-PC cell | - | Growth inhibition assay | - | Inhibition of human MZ1-PC cell growth in a cell viability assay, IC50=0.27999 μM | SANGER |
MZ7-mel cell | - | Growth inhibition assay | - | Inhibition of human MZ7-mel cell growth in a cell viability assay, IC50=117.27 nM | SANGER |
NB14 cell | - | Growth inhibition assay | - | Inhibition of human NB14 cell growth in a cell viability assay, IC50=0.49331 μM | SANGER |
NB69 cell | - | Growth inhibition assay | - | Inhibition of human NB69 cell growth in a cell viability assay, IC50=191.31 nM | SANGER |
NCI-H1648 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H1648 cell growth in a cell viability assay, IC50=0.67266 μM | SANGER |
NCI-H747 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H747 cell growth in a cell viability assay, IC50=0.50637 μM | SANGER |
NOS-1 cell | - | Growth inhibition assay | - | Inhibition of human NOS-1 cell growth in a cell viability assay, IC50=92.65 nM | SANGER |
OCI-AML2 cell | - | Growth inhibition assay | - | Inhibition of human OCI-AML2 cell growth in a cell viability assay, IC50=0.017μM | SANGER |
ONS-76 cell | - | Growth inhibition assay | - | Inhibition of human ONS-76 cell growth in a cell viability assay, IC50=166.62 nM | SANGER |
PSN1 cell | - | Growth inhibition assay | - | Inhibition of human PSN1 cell growth in a cell viability assay, IC50=27.37 nM | SANGER |
RKO cell | - | Growth inhibition assay | - | Inhibition of human RKO cell growth in a cell viability assay, IC50=37.67 nM | SANGER |
SH-4 cell | - | Growth inhibition assay | - | Inhibition of human SH-4 cell growth in a cell viability assay, IC50=3.01 nM | SANGER |
SIG-M5 cell | - | Growth inhibition assay | - | Inhibition of human SIG-M5 cell growth in a cell viability assay, IC50=9.45 nM | SANGER |
SK-MEL-1 cell | - | Growth inhibition assay | - | Inhibition of human SK-MEL-1 cell growth in a cell viability assay, IC50=0.38362 μM | SANGER |
SW872 cell | - | Growth inhibition assay | - | Inhibition of human SW872 cell growth in a cell viability assay, IC50=96.48 nM | SANGER |
UACC-257 cell | - | Growth inhibition assay | - | Inhibition of human UACC-257 cell growth in a cell viability assay, IC50=27.49 nM | SANGER |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网